Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1942 3
1944 1
1946 2
1947 2
1965 1
1971 1
1972 1
1973 2
1974 1
1975 1
1976 3
1977 2
1979 2
1980 1
1981 1
1982 4
1983 1
1984 1
1986 1
1987 1
1988 1
2007 2
2010 1
2011 1
2012 3
2013 3
2014 1
2015 1
2016 1
2017 2
2018 3
2020 3
2021 5
2022 8
2023 8
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.
Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, Xiao J, Hooper AT, Hamilton JD, Musser BJ, Rofail D, Hussein M, Im J, Atmodjo DY, Perry C, Pan C, Mahmood A, Hosain R, Davis JD, Turner KC, Baum A, Kyratsous CA, Kim Y, Cook A, Kampman W, Roque-Guerrero L, Acloque G, Aazami H, Cannon K, Simón-Campos JA, Bocchini JA, Kowal B, DiCioccio AT, Soo Y, Geba GP, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD; Trial Investigators. Weinreich DM, et al. N Engl J Med. 2021 Dec 2;385(23):e81. doi: 10.1056/NEJMoa2108163. Epub 2021 Sep 29. N Engl J Med. 2021. PMID: 34587383 Free PMC article. Clinical Trial.
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.
Dougan M, Nirula A, Azizad M, Mocherla B, Gottlieb RL, Chen P, Hebert C, Perry R, Boscia J, Heller B, Morris J, Crystal C, Igbinadolor A, Huhn G, Cardona J, Shawa I, Kumar P, Adams AC, Van Naarden J, Custer KL, Durante M, Oakley G, Schade AE, Holzer TR, Ebert PJ, Higgs RE, Kallewaard NL, Sabo J, Patel DR, Dabora MC, Klekotka P, Shen L, Skovronsky DM; BLAZE-1 Investigators. Dougan M, et al. N Engl J Med. 2021 Oct 7;385(15):1382-1392. doi: 10.1056/NEJMoa2102685. Epub 2021 Jul 14. N Engl J Med. 2021. PMID: 34260849 Free PMC article. Clinical Trial.
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
O'Brien MP, Forleo-Neto E, Musser BJ, Isa F, Chan KC, Sarkar N, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Hou P, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM; Covid-19 Phase 3 Prevention Trial Team. O'Brien MP, et al. N Engl J Med. 2021 Sep 23;385(13):1184-1195. doi: 10.1056/NEJMoa2109682. Epub 2021 Aug 4. N Engl J Med. 2021. PMID: 34347950 Free PMC article. Clinical Trial.
Fuzzy-Contextual Contrast Enhancement.
Parihar A, Verma O, Khanna C. Parihar A, et al. Among authors: verma o. IEEE Trans Image Process. 2017 Apr;26(4):1810-1819. doi: 10.1109/TIP.2017.2665975. Epub 2017 Feb 8. IEEE Trans Image Process. 2017. PMID: 28186893
Neurosurgery before Science: Taking a Chance.
Verma O, Tripathi M. Verma O, et al. Neurol India. 2024 Sep 1;72(5):1130-1131. doi: 10.4103/neurol-india.Neurol-India-D-24-00497. Epub 2024 Oct 19. Neurol India. 2024. PMID: 39428808 Free article. No abstract available.
Cerebrospinal fluid protein biomarkers in Parkinson's disease.
Faizan M, Sachan N, Verma O, Sarkar A, Rawat N, Pratap Singh M. Faizan M, et al. Among authors: verma o. Clin Chim Acta. 2024 Mar 15;556:117848. doi: 10.1016/j.cca.2024.117848. Epub 2024 Feb 27. Clin Chim Acta. 2024. PMID: 38417781 Review.
Bevacizumab: The future of chronic subdural hematoma.
Verma Y, Abdelghaffar M, Verma O, Gajjar A, Ghozy S, Kallmes DF. Verma Y, et al. Among authors: verma o. Interv Neuroradiol. 2024 Nov 21:15910199241298727. doi: 10.1177/15910199241298727. Online ahead of print. Interv Neuroradiol. 2024. PMID: 39569567 Free PMC article. Review.
Bioactive Molecules Derived from Plants in Managing Dengue Vector Aedes aegypti (Linn.).
Priya SS, Vasantha-Srinivasan P, Altemimi AB, Keerthana R, Radhakrishnan N, Senthil-Nathan S, Kalaivani K, Chandrasekar N, Karthi S, Ganesan R, Alkanan ZT, Pal T, Verma OP, Proćków J. Priya SS, et al. Among authors: verma op. Molecules. 2023 Mar 5;28(5):2386. doi: 10.3390/molecules28052386. Molecules. 2023. PMID: 36903635 Free PMC article. Review.
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
O'Brien MP, Forleo-Neto E, Sarkar N, Isa F, Hou P, Chan KC, Musser BJ, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Brown ER, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Geba GP, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM; COVID-19 Phase 3 Prevention Trial Team. O'Brien MP, et al. JAMA. 2022 Feb 1;327(5):432-441. doi: 10.1001/jama.2021.24939. JAMA. 2022. PMID: 35029629 Free PMC article. Clinical Trial.
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.
Chen P, Nirula A, Heller B, Gottlieb RL, Boscia J, Morris J, Huhn G, Cardona J, Mocherla B, Stosor V, Shawa I, Adams AC, Van Naarden J, Custer KL, Shen L, Durante M, Oakley G, Schade AE, Sabo J, Patel DR, Klekotka P, Skovronsky DM; BLAZE-1 Investigators. Chen P, et al. N Engl J Med. 2021 Jan 21;384(3):229-237. doi: 10.1056/NEJMoa2029849. Epub 2020 Oct 28. N Engl J Med. 2021. PMID: 33113295 Free PMC article. Clinical Trial.
73 results